1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Synthetic Stem Cells Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Synthetic Stem Cells Market, by Application
8.1.1. Cardiovascular Disease
8.1.1.1. Market Revenue and Forecast
8.1.2. Neurological Disorders
8.1.2.1. Market Revenue and Forecast
8.1.3. Cancer
8.1.3.1. Market Revenue and Forecast
8.1.4. Diabetes
8.1.4.1. Market Revenue and Forecast
8.1.5. Gastrointestinal
8.1.5.1. Market Revenue and Forecast
8.1.6. Musculoskeletal Disorders
8.1.6.1. Market Revenue and Forecast
9.1. Synthetic Stem Cells Market, by End-user
9.1.1. Hospitals and surgical centers
9.1.1.1. Market Revenue and Forecast
9.1.2. Academic institutes
9.1.2.1. Market Revenue and Forecast
9.1.3. Research laboratories
9.1.3.1. Market Revenue and Forecast
9.1.4. Pharmaceutical and biotechnology companies
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application
10.1.2. Market Revenue and Forecast, by End-user
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Application
10.1.3.2. Market Revenue and Forecast, by End-user
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Application
10.1.4.2. Market Revenue and Forecast, by End-user
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application
10.2.2. Market Revenue and Forecast, by End-user
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Application
10.2.3.2. Market Revenue and Forecast, by End-user
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Application
10.2.4.2. Market Revenue and Forecast, by End-user
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Application
10.2.5.2. Market Revenue and Forecast, by End-user
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Application
10.2.6.2. Market Revenue and Forecast, by End-user
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application
10.3.2. Market Revenue and Forecast, by End-user
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Application
10.3.3.2. Market Revenue and Forecast, by End-user
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Application
10.3.4.2. Market Revenue and Forecast, by End-user
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Application
10.3.5.2. Market Revenue and Forecast, by End-user
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Application
10.3.6.2. Market Revenue and Forecast, by End-user
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application
10.4.2. Market Revenue and Forecast, by End-user
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Application
10.4.3.2. Market Revenue and Forecast, by End-user
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Application
10.4.4.2. Market Revenue and Forecast, by End-user
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Application
10.4.5.2. Market Revenue and Forecast, by End-user
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Application
10.4.6.2. Market Revenue and Forecast, by End-user
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application
10.5.2. Market Revenue and Forecast, by End-user
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Application
10.5.3.2. Market Revenue and Forecast, by End-user
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Application
10.5.4.2. Market Revenue and Forecast, by End-user
11.1. Brainstorm Cell Therapeutics
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Fate Therapeutics
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Evotec
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cesca Therapeutics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. VistaGen Therapeutics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. North Carolina State University
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Zhengzhou University
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. StemBioSys
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Celularity
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Pluri Inc., formerly Pluristem Therapeutics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
